Studies have shown that deletion of PTPN22 or PTPN2 in CD8 T cells improved tumor clearance in a number of mouse tumor models (Brownlie et al., 2017, 2019; LaFleur et al., 2019; Wiede et al., 2020). Here, PTPN2 is linked to neoplasm.